Jacobson Pharma Corporation Limited

Jacobson Pharma Corporation Limitedverified

2633.HK

Price:

$1.26

Market Cap:

$2.51B

Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-09-21

Stock Exchange

HKSE

Ticker

2633.HK

The PE Ratio as of December 2025 (TTM) for Jacobson Pharma Corporation Limited (2633.HK) is 8.40

According to Jacobson Pharma Corporation Limited’s latest financial reports and current stock price. The company's current PE Ratio is 8.40. This represents a change of 208.23% compared to the average of 2.73 of the last 4 quarters.

Jacobson Pharma Corporation Limited (2633.HK) Historical PE Ratio (quarterly & annually)

How has 2633.HK PE Ratio performed in the past?

The mean historical PE Ratio of Jacobson Pharma Corporation Limited over the last ten years is 10.76. The current 8.40 PE Ratio has changed 7.70% with respect to the historical average. Over the past ten years (40 quarters), 2633.HK's PE Ratio was at its highest in in the March 2015 quarter at 14.43. The PE Ratio was at its lowest in in the September 2024 quarter at 2.19.

Quarterly (TTM)
Annual

Average

10.76

Median

11.42

Minimum

4.17

Maximum

16.34

Jacobson Pharma Corporation Limited (2633.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jacobson Pharma Corporation Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 86.72%

Maximum Annual PE Ratio = 16.34

Minimum Annual Increase = -47.66%

Minimum Annual PE Ratio = 4.17

Quarterly (TTM)
Annual
YearPE RatioChange
20257.7986.72%
20244.17-43.51%
20237.395.37%
20227.01-33.82%
202110.59-18.33%
202012.975.84%
201912.25-25.01%
201816.3416.30%
201714.05-6.97%
201615.10-47.66%

Jacobson Pharma Corporation Limited (2633.HK) Average PE Ratio

How has 2633.HK PE Ratio performed in the past?

The current PE Ratio of Jacobson Pharma Corporation Limited (2633.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

6.45

5-year avg

7.39

10-year avg

10.76

Jacobson Pharma Corporation Limited (2633.HK) PE Ratio vs. Peers

How is 2633.HK’s PE Ratio compared to its peers?

Jacobson Pharma Corporation Limited’s PE Ratio is greater than Golden Throat Holdings Group Company Limited (8.11), less than JBM (Healthcare) Limited (11.47), greater than Essex Bio-Technology Limited (7.22), greater than Hua Medicine (Shanghai) Ltd. (2.74), less than Dawnrays Pharmaceutical (Holdings) Limited (9.67), greater than Clover Biopharmaceuticals, Ltd. (-3.55), less than Chia Tai Enterprises International Limited (9.22), less than MicroPort CardioFlow Medtech Corporation (514.84), greater than MicroTech Medical (Hangzhou) Co., Ltd. (-106.55), greater than Antengene Corporation Limited (-10.92),

Build a custom stock screener for Jacobson Pharma Corporation Limited (2633.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jacobson Pharma Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jacobson Pharma Corporation Limited (2633.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jacobson Pharma Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Jacobson Pharma Corporation Limited's PE Ratio?

How is the PE Ratio calculated for Jacobson Pharma Corporation Limited (2633.HK)?

What is the highest PE Ratio for Jacobson Pharma Corporation Limited (2633.HK)?

What is the 3-year average PE Ratio for Jacobson Pharma Corporation Limited (2633.HK)?

What is the 5-year average PE Ratio for Jacobson Pharma Corporation Limited (2633.HK)?

How does the current PE Ratio for Jacobson Pharma Corporation Limited (2633.HK) compare to its historical average?